[1] |
Sun Jie, Wang Rui, Li Chengxin.
Tumor necrosis factor-α inhibitor?induced psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(9): 821-824.
|
[2] |
Liu Jin, Shen Zhengyu.
Epigenetic regulation in psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(9): 825-829.
|
[3] |
Zheng Jiayuan, Yu Bingqian, Chen Xianxia, Luo Zhicheng.
Characteristics of pruritus in adult patients with psoriasis vulgaris and its effect on quality of life
[J]. Chinese Journal of Dermatology, 2022, 55(9): 790-794.
|
[4] |
Xiao Chunying, Wang Gang.
Roles of Langerhans cells in psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(9): 830-834.
|
[5] |
Zhou Xue, Yu Zengyang, Chen Youdong, Guo Chunyuan, Yu Qian, Hu Yifan, Yao Lingling, Shi Yuling, .
Tumor necrosis factor α-mediated low expression of fatty acid desaturase 2 in psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(9): 752-758.
|
[6] |
Yao Lingling, Yu Zengyang, Guo Chunyuan, Zhou Jing, Cui Lian, Yu Qian, Yu Yingyuan, Zhou Xue, Cai Jiangluyi, Shi Yuling, .
Changes in circadian gene cryptochrome 2 expression in mouse models of psoriasis and HaCaT cells and their underlying mechanisms
[J]. Chinese Journal of Dermatology, 2022, 55(9): 759-766.
|
[7] |
Yu Chen, Wang Gang.
Small-molecule targeted agents: new choices for the treatment of psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(9): 747-751.
|
[8] |
Gao Zirui, Zhao Pei, Dou Yuanqing, Liu Ping, Zhang Jianzhong.
Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis
[J]. Chinese Journal of Dermatology, 2022, 55(7): 562-565.
|
[9] |
Wang Lingyan, Pan Jing, Miao Gang, Chang Xiaodan, Jin Qiuzi, Guo Ningning, Zhang Jiayu.
Analysis of difficult-to-treat sites in patients with psoriasis who received biological therapy
[J]. Chinese Journal of Dermatology, 2022, 55(7): 583-587.
|
[10] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Cyclosporine in the treatment of immune-related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479.
|
[11] |
Huang Xin, Chen Xiaoyun, Li Yaping, Liang Xingkun, Zhang Guiying, Zhou Ying, Zhan Yi, Luo Shuaihantian, Liao Jieyue, Xiao Rong, Long Hai.
Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(6): 486-493.
|
[12] |
Shan Ying, Zuo Yagang.
Correlation between autoimmune bullous diseases and psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455.
|
[13] |
Hu Yebei, Song Xiuzu.
Tranexamic acid for the treatment of melasma
[J]. Chinese Journal of Dermatology, 2022, 55(5): 460-462.
|
[14] |
Li Yan, Li Ming, Xu Wei, Li Linfeng.
Calcium-based antimicrobial peptide compounds cooling gel for the treatment of atopic dermatitis: a randomized, double-blind controlled clinical study
[J]. Chinese Journal of Dermatology, 2022, 55(4): 345-348.
|
[15] |
Liu Bo, Song Xiaoting, Liao Shuanglu, Yu Miao, Luan Tingting, Li Ruoyu, Zhao Zuotao.
Efficacy and safety of baricitinib in the treatment of moderate-to-severe atopic dermatitis: a clinical observation
[J]. Chinese Journal of Dermatology, 2022, 55(4): 304-307.
|